UNSPSC 51373314: Acetaminophen/oxycodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373314 Acetaminophen/oxycodone is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single identifiable recent opportunity—Seminole County, Florida's IFB60459723LAS—does not seek acetaminophen/oxycodone but instead procures naloxone and safe drug deactivation systems, products outside the code's stated category. This mismatch suggests that state and local agencies either tag opioid-related pharmaceutical procurement under misaligned codes or that the code itself sees limited real activity. Where pharmaceutical procurement does occur under health-related UNSPSC categories, it typically flows through county and municipal health departments and community health programs focused on emergency response, addiction services, and public health initiatives rather than general medical supply chains.

The Seminole County solicitation, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic submission, included drug-free workplace and E-Verify compliance, and carried a two-year initial term with a one-year renewal option. No explicit set-aside designations were noted. The mismatch between the code's pharmaceutical scope and the actual procurement under it—combined with a single recent opportunity outside the acetaminophen/oxycodone category—indicates limited near-term activity worth pursuing directly under this commodity code.